Pfizer (Pharmaceuticals) Overview

  • Year Founded
  • 1848

Year Founded

  • Status
  • Public

  • Employees
  • 88,000

Employees

  • Stock Symbol
  • PFE

Stock Symbol

  • Investments
  • 149

  • Share Price
  • $25.74
  • (As of Friday Closing)

Pfizer (Pharmaceuticals) General Information

Description

Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding covid-19-related product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.

Contact Information

Website
www.pfizer.com
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • 66 Hudson Boulevard East
  • New York, NY 10001-2192
  • United States
+1 (800)
Primary Industry
Pharmaceuticals
Other Industries
Discovery Tools (Healthcare)
Biotechnology
Drug Discovery
Stock Exchange
NYS
Vertical(s)
Corporate Office
  • 66 Hudson Boulevard East
  • New York, NY 10001-2192
  • United States
+1 (800)

Pfizer (Pharmaceuticals) Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Pfizer (Pharmaceuticals) Stock Performance

As of 07-Feb-2025, Pfizer (Pharmaceuticals)’s stock price is $25.74. Its current market cap is $146B with 5.67B shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$25.74 $25.83 $24.48 - $31.54 $146B 5.67B 43.5M $1.42

Pfizer (Pharmaceuticals) Financials Summary

As of 31-Dec-2024, Pfizer (Pharmaceuticals) has a trailing 12-month revenue of $63.6B.

In Thousands,
USD
TTM 31-Dec-2024 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022
EV 207,282,246 207,282,246 182,245,239 287,439,237
Revenue 63,627,000 63,627,000 58,496,000 100,330,000
EBITDA 15,855,000 15,855,000 7,933,000 40,780,000
Net Income 8,031,000 8,031,000 2,119,000 31,372,000
Total Assets 226,501,000 197,205,000
Total Debt 0 0 70,845,000 34,859,000
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Pfizer (Pharmaceuticals) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Pfizer (Pharmaceuticals)‘s full profile, request access.

Request a free trial

Pfizer (Pharmaceuticals) Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding covid-19-re
Pharmaceuticals
New York, NY
88,000 As of 2023

Rahway, NJ
 

Middlesex, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Pfizer (Pharmaceuticals) Competitors (27)

One of Pfizer (Pharmaceuticals)’s 27 competitors is Merck & Co., a Corporation company based in Rahway, NJ.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Merck & Co. Corporation Rahway, NJ
GSK Corporation Middlesex, United Kingdom
Johnson & Johnson Corporation New Brunswick, NJ
AbbVie Corporation North Chicago, IL
AstraZeneca Formerly PE-Backed Cambridge, United Kingdom
You’re viewing 5 of 27 competitors. Get the full list »

Pfizer (Pharmaceuticals) Patents

Pfizer (Pharmaceuticals) Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2024151316-A Rna molecule Pending 11-Apr-2023
JP-2024075506-A Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof Pending 22-Nov-2022
JP-2024047569-A 3,4-dihydro-2,7-naphthyridine-1,6(2h,7h)-dione as mek inhibitor Pending 26-Sep-2022
JP-2024041730-A Modulator for sting (stimulator of interferon genes) Pending 14-Sep-2022
JP-2024000530-A Escherichia coli fimh mutants and uses thereof Pending 20-Jun-2022
To view Pfizer (Pharmaceuticals)’s complete patent history, request access »

Pfizer (Pharmaceuticals) Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Pfizer (Pharmaceuticals) Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Pfizer (Pharmaceuticals)‘s full profile, request access.

Request a free trial

Pfizer (Pharmaceuticals) Investments & Acquisitions (149)

Pfizer (Pharmaceuticals)’s most recent deal was a Later Stage VC with F2G for . The deal was made on 12-Sep-2024.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
F2G 12-Sep-2024 Later Stage VC Drug Discovery
Vedanta Biosciences 05-Aug-2024 Later Stage VC Drug Discovery
CytoReason 15-Jul-2024 Later Stage VC Discovery Tools (Healthcare)
Seagen 14-Dec-2023 Merger/Acquisition Drug Discovery
Theragraph 03-Aug-2023 Accelerator/Incubator Other Healthcare Technology Systems
You’re viewing 5 of 149 investments and acquisitions. Get the full list »

Pfizer (Pharmaceuticals) ESG

Risk Overview

Risk Rating

Updated January, 22, 2025

19.36 | Low Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 15,120

Rank

Percentile

Pharmaceuticals

Industry

of 853

Rank

Percentile

Pharmaceuticals

Subindustry

of 425

Rank

Percentile

To view Pfizer (Pharmaceuticals)’s complete esg history, request access »

Pfizer (Pharmaceuticals) Exits (45)

Pfizer (Pharmaceuticals)’s most recent exit was on 30-Jun-2023 from Caribou Biosciences. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
Caribou Biosciences 30-Jun-2023 Completed
Telavant 01-Dec-2022 Completed
  • 2 buyers
Akero Therapeutics 17-Jun-2022 Completed
GeneDx Holding 02-May-2022 Completed
MAI Therapeutics 20-Aug-2021 Early Stage VC Completed
  • 6 buyers
You’re viewing 5 of 45 exits. Get the full list »

Affiliates

Subsidiaries (20)

Name Industry Location Year Founded
Pfizer Saudi Riyadh, Saudi Arabia 2017
Biohaven Tortola, VI 2013
Lucira Health Emeryville, CA 2012
Hospira 401(K) Retirement Savings Plan Peapack, NJ 2004
Pfizer Ventures New York, NY 2004
You’re viewing 5 of 20 affiliates. Get the full list.  »

Pfizer (Pharmaceuticals) FAQs

  • When was Pfizer (Pharmaceuticals) founded?

    Pfizer (Pharmaceuticals) was founded in 1848.

  • Where is Pfizer (Pharmaceuticals) headquartered?

    Pfizer (Pharmaceuticals) is headquartered in New York, NY.

  • What is the size of Pfizer (Pharmaceuticals)?

    Pfizer (Pharmaceuticals) has 88,000 total employees.

  • What industry is Pfizer (Pharmaceuticals) in?

    Pfizer (Pharmaceuticals)’s primary industry is Pharmaceuticals.

  • Is Pfizer (Pharmaceuticals) a private or public company?

    Pfizer (Pharmaceuticals) is a Public company.

  • What is Pfizer (Pharmaceuticals)’s stock symbol?

    The ticker symbol for Pfizer (Pharmaceuticals) is PFE.

  • What is the current stock price of Pfizer (Pharmaceuticals)?

    As of 07-Feb-2025 the stock price of Pfizer (Pharmaceuticals) is $25.74.

  • What is the current market cap of Pfizer (Pharmaceuticals)?

    The current market capitalization of Pfizer (Pharmaceuticals) is $146B.

  • What is Pfizer (Pharmaceuticals)’s current revenue?

    The trailing twelve month revenue for Pfizer (Pharmaceuticals) is $63.6B.

  • Who are Pfizer (Pharmaceuticals)’s competitors?

    Merck & Co., GSK, Johnson & Johnson, AbbVie, and AstraZeneca are some of the 27 competitors of Pfizer (Pharmaceuticals).

  • What is Pfizer (Pharmaceuticals)’s annual earnings per share (EPS)?

    Pfizer (Pharmaceuticals)’s EPS for 12 months was $1.42.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »